Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Breast Cancer Breast Cancer for January/February 2021 U.S. mothers underestimate role breastfeeding plays in curbing breast cancer, More must reads Breast Cancer for November/December 2020 Long-term APBI cosmetic, toxicity data reported WBI has the edge Practice-confirming results, Pregnancy after breast cancer is rockier but doesn't increase recurrence risk, Breast surgery may be a gateway to addictive medication use, Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest, More must readsBreast Cancer for September/October 2020 Combined features of benign breast disease tied to breast cancer risk, Restarting breast cancer screening after COVID-19 disruption not so simple, AI algorithm on par with radiologists as mammogram reader, Study supports multigene panel testing for all breast cancer patients with second primary cancers, More must readsBreast Cancer for July/August 2020 Beyond baseline, DBT no better than mammography for dense breasts, System provides ‘faster, less invasive’ method for breast cancer detection, Higher death rate seen in cancer patients with nosocomial COVID-19, Postmenopausal use of estrogen alone lowers breast cancer cases, deaths, Early screening may halve breast cancer mortality in childhood cancer survivors, More must readsBreast Cancer for May/June 2020 Novel SERD, LSZ102, shows promise for pretreated ER+ breast cancer, Treating primary tumor doesn’t improve OS in stage IV breast cancer, Pyrotinib bests lapatinib in HER2+ metastatic breast cancer, Expanding the role of PARP inhibitors in breast cancer, ALTERNATE trial: No fulvestrant benefit in locally advanced ER+ HER2– breast cancer, More must readsPages1 2 3 4 5 6 last »
